Combination analgesic development for enhanced clinical efficacy (the CADENCE trial): a double-blind, controlled trial of an alpha-lipoic acid-pregabalin combination for fibromyalgia pain.

Fibromyalgia pain may respond to different drugs. However only 40 – 60 % of people with fibromyalgia notice the drugs decrease their pain. Those who do see a decrease, experience a reduction of …

Fibromyalgia pain may respond to different drugs. However only 40 – 60 % of people with fibromyalgia notice the drugs decrease their pain. Those who do see a decrease, experience a reduction of …

This content requires membership to view.
Please Join Now or sign in below.
Already a member? Log in here
en_CAEN